[
  {
    "ts": null,
    "headline": "WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down",
    "summary": "West Pharmaceutical's overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.",
    "url": "https://finnhub.io/api/news?id=e7476ffbd676d5578d289bd1abd84db47425b786b4d744f76f6642db38bb6ee7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739462040,
      "headline": "WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down",
      "id": 132743933,
      "image": "https://media.zenfs.com/en/zacks.com/f4f040597ee01c61420a977a95c5b391",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "West Pharmaceutical's overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.",
      "url": "https://finnhub.io/api/news?id=e7476ffbd676d5578d289bd1abd84db47425b786b4d744f76f6642db38bb6ee7"
    }
  },
  {
    "ts": null,
    "headline": "QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract",
    "summary": "Despite solid performances by the Labs and Immunohematology units and China and Other regions, QDEL reports soft overall top-line results in fourth-quarter 2024.",
    "url": "https://finnhub.io/api/news?id=1ac60a12d90336a9029734ff8a8815797a9a4d354307cf5f73eece0084446387",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739461860,
      "headline": "QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract",
      "id": 132743934,
      "image": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Despite solid performances by the Labs and Immunohematology units and China and Other regions, QDEL reports soft overall top-line results in fourth-quarter 2024.",
      "url": "https://finnhub.io/api/news?id=1ac60a12d90336a9029734ff8a8815797a9a4d354307cf5f73eece0084446387"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises",
    "summary": "GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.",
    "url": "https://finnhub.io/api/news?id=8723d5cd9878779553619516c4587e54d1cd5a6f6155a82d38b9802be79e0a87",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739452920,
      "headline": "GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises",
      "id": 132743935,
      "image": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.",
      "url": "https://finnhub.io/api/news?id=8723d5cd9878779553619516c4587e54d1cd5a6f6155a82d38b9802be79e0a87"
    }
  }
]